So, La Monica et al. examined the role of phosphorylated Rb as a biomarker and/or as a target in NSCLC-osimertinibin-resistant cells and showed that Rb phosphorylation was maintained in the majority of NSCLC cell lines with resistance to osimertinib [71]. The gene discussed is RB1; the disease is non-small cell lung carcinoma.